Compare Centene Corp (CNC) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Centene Corp vs ResMed Inc. — how do they compare? Centene Corp trades at $65.13 (market cap $32.05B), while ResMed Inc. trades at $220.4 (market cap $32.61B). The key difference: Centene Corp and ResMed Inc. are close in size by market cap, and ResMed Inc. pays a 1.17% dividend while Centene Corp pays none. Which is the better fit depends on your goals.
| CNC | RMD | |
|---|---|---|
Market Cap | $32.05B | $32.61B |
Sector | Health | Health |
52-Week High | $68.72 | $293.73 |
52-Week Low | $26.17 | $182.82 |
Enterprise Value | $21.10B | $31.97B |
Dividend Yield | — | 1.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Centene Corp
Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.
Read more on CNC →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
